Who Exports Docetaxel from India — 253 Suppliers Behind a $39.6M Market
India's docetaxel export market is supplied by 253 active exporters who collectively shipped $39.6M across 2,634 shipments. FRESENIUS KABI ONCOLOGY LIMITED leads with a 21.1% market share, followed by MYLAN LABORATORIES LIMITED and KWALITY PHARMACEUTICALS LIMITED. The top 5 suppliers together control 63.7% of total export value, reflecting a concentrated market structure.
Top Docetaxel Exporters from India — Ranked by Export Value
FRESENIUS KABI ONCOLOGY LIMITED is the leading docetaxel exporter from India, holding a 21.1% share of the $39.6M market across 2,634 shipments from 253 exporters. The top 5 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, MYLAN LABORATORIES LIMITED, KWALITY PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, JODAS EXPOIM PRIVATE LIMITED — collectively control 63.7% of total export value, indicating a moderately concentrated market. Individual shares are: FRESENIUS KABI ONCOLOGY LIMITED (21.1%), MYLAN LABORATORIES LIMITED (17.7%), KWALITY PHARMACEUTICALS LIMITED (10.3%), INTAS PHARMACEUTICALS LIMITED (8.0%), JODAS EXPOIM PRIVATE LIMITED (6.5%).
Top Docetaxel Exporters from India
Ranked by export value · 253 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI ONCOLOGY LIMITED VEXDO 80DOCETAXEL INJ. 120MG/6ML VIALDAXOTEL INJ. 80MG/4ML VIAL | $8.4M | 21 | 21.1% |
| 2 | MYLAN LABORATORIES LIMITED DOCETAXEL INJ USP 10MG/ML 16ML 1S MYL USDOCETAXEL INJ.160MG-USPREMIER-F000052363DOCETAXEL INJ USP 160MG/16 ML AP US | $7.0M | 1 | 17.7% |
| 3 | KWALITY PHARMACEUTICALS LIMITED DOCETAXEL INJECTION USP 80MG/2ML SOLVENTDOCEMYRA-120 DOCETAXEL 120 MG INJECTIONIPDOCEMYRA-80 DOCETAXEL 80 MG INJECTION IP | $4.1M | 10 | 10.3% |
| 4 | INTAS PHARMACEUTICALS LIMITED DOCETAXEL INJ USP 10MG/ML 16ML 1S MYL USDOCETAXEL INJ.160MG-USPREMIER-F000052363VEXDO 80 | $3.2M | 9 | 8.0% |
| 5 | JODAS EXPOIM PRIVATE LIMITED DOCETAXEL CONCENTRATE FOR SOLUTION FOR I | $2.6M | 1 | 6.5% |
| 6 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED DOCETAXEL INJ USP 10MG/ML 16ML 1S MYL USDOCETAXEL INJ.160MG-USPREMIER-F000052363DOCETAXEL INJ USP 160MG/16 ML AP US | $1.8M | 4 | 4.4% |
| 7 | ALEMBIC PHARMACEUTICALS LIMITED DOCETAXEL INJ USP 10MG/ML 16ML 1S MYL USDOCETAXEL INJ.160MG-USPREMIER-F000052363DOCETAXEL INJ USP 160MG/16 ML AP US | $1.3M | 1 | 3.3% |
| 8 | EUGIA PHARMA SPECIALITIES LIMITED DOCETAXEL INJ USP 10MG/ML 16ML 1S MYL USDOCETAXEL INJ.160MG-USPREMIER-F000052363DOCETAXEL INJ USP 160MG/16 ML AP US | $1.1M | 2 | 2.8% |
| 9 | NV REMEDIES PRIVATE LIMITED | $959.1K | 4 | 2.4% |
| 10 | VENUS REMEDIES LIMITED DOCETAXEL INJ. 80MG/4ML VIALDOCETAXEL KABI INJECTION 80MG/4ML VIAL BDOCETAXEL KABI INJ. 160MG/8ML VIAL,BATC | $829.1K | 16 | 2.1% |
| 11 | VEXXA LIFESCIENCES PVT. LTD. VEXDO 80 | $817.5K | 2 | 2.1% |
| 12 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $817.0K | 1 | 2.1% |
| 13 | NAPROD LIFE SCIENCES PRIVATE LIMITED VEXDO 80DAXEL INJ. 80MG/4ML VIAL | $608.8K | 14 | 1.5% |
| 14 | THERDOSE PHARMA PRIVATE LIMITED VEXDO 80 | $490.0K | 6 | 1.2% |
| 15 | UNITED BIOTECH PRIVATE LIMITED | $380.9K | 10 | 1.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Docetaxel exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | Not Listed | Yes | Yes | Not Found | WHO-GMP certified; EU GMP compliant. |
| KWALITY PHARMACEUTICALS LIMITED | Not Listed | Yes | Yes | Not Found | WHO-GMP certified; EU GMP compliant. |
| ALEMBIC PHARMACEUTICALS LIMITED | Approved | Yes | Yes | 223 | FDA-approved; WHO-GMP certified; EU GMP compliant; 223 ANDA approvals. |
| INTAS PHARMACEUTICALS LIMITED | Approved | Yes | Yes | Not Found | FDA-approved; WHO-GMP certified; EU GMP compliant; received FDA warning letter i |
| MYLAN LABORATORIES LIMITED | Approved | Yes | Yes | Not Found | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED | Approved | Yes | Yes | Not Found | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| VENUS REMEDIES LIMITED | Not Listed | Yes | Yes | Not Found | WHO-GMP certified; EU GMP compliant. |
| EUGIA PHARMA SPECIALITIES LIMITED | Approved | Yes | Yes | Not Found | FDA-approved; WHO-GMP certified; EU GMP compliant. |
TransData Nexus reviewed the regulatory standing of 8 leading Docetaxel exporters from India. 5 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Docetaxel sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Pharma City of India," is a pivotal hub for pharmaceutical manufacturing and research. The city contributes approximately 40% of India's bulk drug production and hosts over 2,000 pharmaceutical companies. Notable firms such as Dr. Reddy's Laboratories, Aurobindo Pharma, and Natco Pharma are headquartered here. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position in the global pharmaceutical landscape.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output. The region is home to major companies like Alembic Pharmaceuticals, Sun Pharmaceutical Industries, and Zydus Cadila Healthcare. Vadodara, in particular, has a rich history in pharmaceuticals, with Alembic Pharmaceuticals established as early as 1907.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. The region hosts several pharmaceutical giants, including Sun Pharmaceutical Industries and Lupin Limited, which leverage the strategic location for efficient distribution.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical cluster, primarily due to favorable tax incentives. The region offers excise duty exemptions and income tax benefits, attracting numerous pharmaceutical companies to set up manufacturing units. This has led to substantial growth in pharmaceutical production and exports from the area.
5Sourcing Recommendations
- Evaluate Supplier Capabilities: Assess the production capacities and quality standards of top exporters like Fresenius Kabi Oncology Limited and Mylan Laboratories Limited to ensure they meet your sourcing requirements.
- Diversify Supplier Base: Given the concentration of exports among a few companies, consider engaging with emerging suppliers to mitigate risks associated with over-reliance on a limited number of sources.
- Leverage Regional Strengths: Utilize the bulk drug manufacturing capabilities of Hyderabad and the formulation expertise of the Ahmedabad-Vadodara corridor to optimize your supply chain.
- Monitor Regulatory Compliance: Ensure that all suppliers adhere to international regulatory standards, such as those set by the FDA and WHO, to maintain product quality and facilitate smooth export processes.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Docetaxel exporters from India
Fresenius Kabi Oncology Limited — Fresenius Kabi partners with TQ Therapeutics on cell therapy technology
Fresenius Kabi entered into a strategic agreement with TQ Therapeutics to develop, manufacture, and distribute products incorporating TQ's proprietary cell selection technology, aiming to enhance cell and gene therapy accessibility. - IMPACT: This collaboration is not expected to directly impact Docetaxel exports.
Impact: This collaboration is not expected to directly impact Docetaxel exports.
Fresenius Kabi Oncology Limited — Fresenius Kabi acquires majority stake in mAbxience
Fresenius Kabi acquired a 55% stake in mAbxience, enhancing its presence in the biopharmaceuticals market and expanding its biosimilars portfolio. - IMPACT: This acquisition may lead to a diversified product focus, potentially affecting Docetaxel export volumes.
Impact: This acquisition may lead to a diversified product focus, potentially affecting Docetaxel export volumes.
Mylan Laboratories Limited — Mylan merges with Upjohn to form Viatris
Mylan merged with Pfizer's Upjohn division to create Viatris, aiming to provide access to medicines globally. - IMPACT: The merger could influence Docetaxel export strategies due to organizational restructuring.
Impact: The merger could influence Docetaxel export strategies due to organizational restructuring.
Common Questions — Docetaxel Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which docetaxel supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, FRESENIUS KABI ONCOLOGY LIMITED leads with 356 recorded shipments worth $8.4M. MYLAN LABORATORIES LIMITED (69 shipments) and KWALITY PHARMACEUTICALS LIMITED (18 shipments) are also established high-volume exporters.
Q How many docetaxel manufacturers are there in India?
India has 253 active docetaxel exporters with a combined export market of $39.6M across 2,634 shipments to 120 countries. The top 5 suppliers hold 63.7% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for docetaxel from India?
Average FOB unit price: $61.31 per unit, ranging from $0.01 to $49422.63. Average shipment value: $15.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 253 verified Indian exporters of Docetaxel ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,634 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 120 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,634 Verified Shipments
253 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists